GSRRX
Price
$11.05
Change
-$0.31 (-2.73%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

GSRRX vs VFINX

Header iconGSRRX vs VFINX Comparison
Open Charts GSRRX vs VFINXBanner chart's image
Goldman Sachs Rising Dividend Gr R
Price$11.05
Change-$0.31 (-2.73%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
GSRRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSRRX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRRX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. GSRRX (477M). GSRRX pays higher dividends than VFINX: GSRRX (2.56) vs VFINX (1.24). GSRRX was incepted earlier than VFINX: GSRRX (13 years) vs VFINX (48 years). GSRRX is a more actively managed with annual turnover of: 45.00 vs. VFINX (2.00). GSRRX (0) and VFINX (0) have matching initial minimum investment requirements. VFINX annual gain was more profitable for investors over the last year : 27.63 vs. GSRRX (3.08). VFINX return over 5 years is better than : 88.65 vs. GSRRX (17.02).
GSRRXVFINXGSRRX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years48 years-
Gain YTD2.23927.2758%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets477M1.37T0%
Annual Yield % from dividends2.561.24207%
Returns for 1 year3.0827.6311%
Returns for 3 years-3.3730.99-11%
Returns for 5 years17.0288.6519%
Returns for 10 years-38.10193.62-20%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc